دورية أكاديمية

Fatal granulomatous amebic encephalitis initially presenting with a cutaneous lesion.

التفاصيل البيبلوغرافية
العنوان: Fatal granulomatous amebic encephalitis initially presenting with a cutaneous lesion.
المؤلفون: Gramp PE; Dermatology Department, Gold Coast University Hospital, Gold Coast, Queensland, Australia., Dooley J; NH Diagnostics, Gold Coast, Queensland, Australia., O'Brien B; Sullivan Nicolaides Pathology, Queensland, Brisbane, Australia., Jones A; Infectious Disease Department, Gold Coast University Hospital, Gold Coast, Queensland, Australia., Tan L; Neurosurgery Department, Pindara Hospital, Queensland, Gold Coast, Australia., Robson J; Sullivan Nicolaides Pathology, Queensland, Brisbane, Australia., Robertson T; Royal Brisbane and Women's Hospital, Queensland, Brisbane, Australia., Simos P; Infectious Disease Department, Gold Coast University Hospital, Gold Coast, Queensland, Australia., Fuller R; Gold Coast University Hospital, Gold Coast, Queensland, Australia., Gramp DV; Dermatology Department, Gold Coast University Hospital, Gold Coast, Queensland, Australia., Meumann EM; Sullivan Nicolaides Pathology, Queensland, Brisbane, Australia.
المصدر: The Australasian journal of dermatology [Australas J Dermatol] 2023 Aug; Vol. 64 (3), pp. e256-e261. Date of Electronic Publication: 2023 May 08.
نوع المنشور: Case Reports; Journal Article
اللغة: English
بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: Australia NLM ID: 0135232 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1440-0960 (Electronic) Linking ISSN: 00048380 NLM ISO Abbreviation: Australas J Dermatol Subsets: MEDLINE
أسماء مطبوعة: Publication: New South Wales : Wiley-Blackwell
Original Publication: [Sydney] Australasian College of Dermatologists.
مواضيع طبية MeSH: Balamuthia mandrillaris* , Amebiasis*/diagnosis , Infectious Encephalitis*/diagnosis, Humans ; Male ; Aged ; Fatal Outcome ; Biopsy ; Skin/pathology ; Antiprotozoal Agents/therapeutic use ; Fluconazole/therapeutic use
مستخلص: We present a case of a 66-year-old man with a cutaneous Balamuthia mandrillaris lesion that progressed to fatal granulomatous amoebic encephalitis. We provide a summary of Australian cases and describe the clinical features and approach to diagnosing this rare but devastating condition, including the importance of PCR for diagnosis.
(© 2023 Australasian College of Dermatologists.)
References: Qvarnstrom Y, Visvesvara GS, Sriram R, da Silva AJ. Multiplex real-time PCR assay for simultaneous detection of Acanthamoeba spp., Balamuthia mandrillaris, and Naegleria fowleri. J Clin Microbiol. 2006;44(10):3589-95. https://doi.org/10.1128/JCM.00875-06.
Schuster FL, Visvesvara GS. Free-living amoebae as opportunistic and non-opportunistic pathogens of humans and animals. Int J Parasitol. 2004;34(9):1001-27. https://doi.org/10.1016/j.ijpara.2004.06.004.
Visvesvara GS, Martinez AJ, Schuster FL, Leitch GJ, Wallace SV, Sawyer TK, et al. Leptomyxid ameba, a new agent of amebic meningoencephalitis in humans and animals. J Clin Microbiol. 1990;28(12):2750-6. https://doi.org/10.1128/jcm.28.12.2750-2756.1990.
Visvesvara GS, Schuster FL, Martinez AJ. Balamuthia mandrillaris, N. G., N. Sp., agent of amebic meningoencephalitis in humans and other animals. J Eukaryot Microbiol. 1993;40(4):504-14. https://doi.org/10.1111/j.1550-7408.1993.tb04943.x.
Cope JR, Landa J, Nethercut H, Collier SA, Glaser C, Moser M, et al. The epidemiology and clinical features of Balamuthia mandrillaris disease in the United States, 1974-2016. Clin Infect Dis. 2019;68(11):1815-22. https://doi.org/10.1093/cid/ciy813.
Alvarez P, Torres-Cabala C, Gotuzzo E, Bravo F. Cutaneous balamuthiasis: A clinicopathological study. JAAD Int. 2022;6:51-8. https://doi.org/10.1016/j.jdin.2021.11.005.
Moriarty P, Burke C, McCrossin D, Campbell R, Cherian S, Shahab MS, et al. Balamuthia mandrillaris encephalitis: survival of a child with severe meningoencephalitis and review of the literature. J Pediatric Infect Dis Soc. 2014;3(1):e4-9. https://doi.org/10.1093/jpids/pit033.
Doyle JS, Campbell E, Fuller A, Spelman DW, Cameron R, Malham G, et al. Balamuthia mandrillaris brain abscess successfully treated with complete surgical excision and prolonged combination antimicrobial therapy. J Neurosurg. 2011;114(2):458-62. https://doi.org/10.3171/2010.10.JNS10677.
Hill CP, Damodaran O, Walsh P, Jevon GP, Blyth CC. Balamuthia amebic meningoencephalitis and mycotic aneurysms in an infant. Pediatr Neurol. 2011;45(1):45-8. https://doi.org/10.1016/j.pediatrneurol.2011.05.003.
Reed RP, Cooke-Yarborough CM, Jaquiery AL, Kemp AS, Su JC, Grimwood K, et al. Fatal granulomatous amoebic encephalitis caused by Balamuthia mandrillaris. Med J Aust. 1997;167(2):82-4. https://doi.org/10.5694/j.1326-5377.1997.tb138785.x.
Carter RF, Cullity GJ, Ojeda VJ, Silberstein P, Willaert E. A fatal case of meningoencephalitis due to a free-living amoeba of uncertain identity-probably Acanthamoeba sp. Pathology. 1981;13(1):51-68. https://doi.org/10.3109/00313028109086829.
Dyke JM, White JN, Speers DJ, Kang ARW, Fabian VA. A detailed neuropathological assessment of a Western Australian case of Balamuthia mandrillaris amoebic encephalitis. Pathology. 2021;53:S29-30. https://doi.org/10.1016/j.pthol.2021.06.039.
Finnin PJ, Visvesvara GS, Campbell BE, Fry DR, Gasser RB. Multifocal Balamuthia mandrillaris infection in a dog in Australia. Parasitol Res. 2007;100(2):423-6. https://doi.org/10.1007/s00436-006-0302-0.
Schuster FL, Dunnebacke TH, Booton GC, Yagi S, Kohlmeier CK, Glaser C, et al. Environmental isolation of Balamuthia mandrillaris associated with a case of amebic encephalitis. J Clin Microbiol. 2003;41(7):3175-80. https://doi.org/10.1128/JCM.41.7.3175-3180.2003.
Centers for Disease C, Prevention. Notes from the field: transplant-transmitted Balamuthia mandrillaris - Arizona, 2010. MMWR Morb Mortal Wkly Rep. 2010;59(36):1182.
Centers for Disease C, Prevention. Balamuthia mandrillaris transmitted through organ transplantation - Mississippi, 2009. MMWR Morb Mortal Wkly Rep. 2010;59(36):1165-70.
Wang L, Cheng W, Li B, Jian Z, Qi X, Sun D, et al. Balamuthia mandrillaris infection in China: a retrospective report of 28 cases. Emerg Microbes Infect. 2020;9(1):2348-57. https://doi.org/10.1080/22221751.2020.1835447.
Guarner J, Bartlett J, Shieh WJ, Paddock CD, Visvesvara GS, Zaki SR. Histopathologic spectrum and immunohistochemical diagnosis of amebic meningoencephalitis. Mod Pathol. 2007;20(12):1230-7. https://doi.org/10.1038/modpathol.3800973.
Centers for Disease Control and Prevention. Parasites - Balamuthia mandrillaris - Granulomatous Amebic Encephalitis (GAE). Diagnosis and Detection. Available at: https://www.cdc.gov/parasites/balamuthia/diagnosis-hcp.html. Accessed 16 October 2022.
Recavarren-Arce S, Velarde C, Gotuzzo E, Cabrera J. Amoeba angeitic lesions of the central nervous system in Balamuthia mandrilaris amoebiasis. Hum Pathol. 1999;30(3):269-73. https://doi.org/10.1016/s0046-8177(99)90004-7.
Xu C, Wu X, Tan M, Wang D, Wang S, Wu Y. Subacute Balamuthia mandrillaris encephalitis in an immunocompetent patient diagnosed by next-generation sequencing. J Int Med Res. 2022;50(5):3000605221093217. https://doi.org/10.1177/03000605221093217.
Hirakata S, Sakiyama Y, Yoshimura A, et al. The application of shotgun metagenomics to the diagnosis of granulomatous amoebic encephalitis due to Balamuthia mandrillaris: a case report. BMC Neurol. 2021;21(1):392. https://doi.org/10.1186/s12883-021-02418-y.
Centers for Disease Control and Prevention. Parasites - Balamuthia mandrillaris - Granulomatous Amebic Encephalitis (GAE). Treatment. Available at: https://www.cdc.gov/parasites/balamuthia/treatment-hcp.html. Accessed 16 October 2022.
Spottiswoode N, Pet D, Kim A, Gruenberg K, Shah M, Ramachandran A, et al. Successful treatment of Balamuthia mandrillaris granulomatous amebic encephalitis with nitroxoline. Emerg Infect Dis. 2023;29(1):197-201. https://doi.org/10.3201/eid2901.221531.
فهرسة مساهمة: Keywords: Balamuthia mandrillaris; Amebiasis; Balamuthia mandrillaris CNS infection; amebic; infectious encephalitis; meningoencephalitis
المشرفين على المادة: 0 (Antiprotozoal Agents)
8VZV102JFY (Fluconazole)
53EY29W7EC (miltefosine)
تواريخ الأحداث: Date Created: 20230508 Date Completed: 20230820 Latest Revision: 20230820
رمز التحديث: 20240628
DOI: 10.1111/ajd.14068
PMID: 37154242
قاعدة البيانات: MEDLINE
الوصف
تدمد:1440-0960
DOI:10.1111/ajd.14068